MPM BIOIMPACT LLC
Top Portfolio Positions
41 positions ·
$1,839,438,406 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| DBVT |
DBV Technologies S.A.
Healthcare
|
31,280,167 | $653,442,688 | 35.52% | |
| CGEM |
Cullinan Therapeutics, Inc.
Healthcare
|
7,648,268 | $108,681,888 | 5.91% | |
| AKTS |
Aktis Oncology, Inc.
Healthcare
|
4,835,872 | $86,513,750 | 4.70% | |
| LQDA |
Liquidia Corp
Healthcare
|
1,405,158 | $53,030,662 | 2.88% | |
| ALMS |
Alumis Inc.
Healthcare
|
2,386,529 | $52,575,233 | 2.86% | |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
1,660,696 | $52,311,924 | 2.84% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
506,776 | $49,283,966 | 2.68% | |
| AGIO |
Agios Pharmaceuticals, Inc.
Healthcare
|
1,306,261 | $44,190,809 | 2.40% | |
| CORT |
Corcept Therapeutics Inc
Healthcare
|
985,700 | $39,733,567 | 2.16% | |
| TRVI |
Trevi Therapeutics, Inc.
Healthcare
|
3,298,430 | $39,350,269 | 2.14% |
Portfolio Trend
25 quarters · across all stocks
Holdings in TVTX
Shares Held
Position Value (USD)
10 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $33,672,274 | 1,133,365 | Shares | Sole | 2026-05-15 | |
| 2023-09-30 | $4,942,443 | 552,846 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $8,491,714 | 552,846 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $7,053,808 | 313,642 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $5,924,382 | 281,711 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $6,811,974 | 276,460 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,734,728 | 277,950 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $7,162,771 | 277,950 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $8,936,198 | 287,893 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $7,432,988 | 306,515 | Shares | Sole | 2021-11-15 | |
| No 13F history on record for this holder in this stock. | ||||||